DecodeME in the media


A new study says people with chronic fatigue syndrome have differences in their DNA, supporting the claim that the condition may not be psychological in origin.

Researchers at the University of Edinburgh said they found eight areas of genetic code that are different in people suffering from myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) compared to healthy participants.

According to a release from the University of Edinburgh, the findings are the first time “robust evidence” has been found that shows “genes contribute to a person’s chance of developing the disease.”

The condition typically results in severe fatigue, pain, and brain fog, even after light bouts of physical or mental activity. Around 67 million people globally are thought to suffer from ME/CFS, but no official diagnostic test or cure exists for the long misunderstood condition.


The landmark DecodeME study examined DNA samples from 15,579 people who reported having the condition and nearly 260,000 people without it. People reporting ME/CFS were more often found to have gene variants linked to the immune and nervous system.

“This is a wakeup call. These extraordinary DNA results speak the language of ME/CFS, often recounting people’s ME/CFS symptoms,” said DecodeME investigator from the University of Edinburgh, Professor Chris Ponting.

At least two of the gene regions are connected to how the body responds to infection. This finding aligns with reports that symptoms often follow an infectious illness.

Another previously identified gene region was found to be connected to chronic pain, yet another symptom that sufferers commonly report.

“DecodeME has revealed genetic results, which should prove game changing in the ME/CFS research field, and that also align with decades of patients reporting on their experiences,” said DecodeME co-investigator Andy Devereux-Cooke.

“These results will not mean that a test or cure will be developed straight away, but they will lead to a greater understanding of ME/CFS. DecodeME also shows the incredible level of support that the ME/CFS patient community can give to research that involves them on a deep and meaningful level. Without the community, we could not have achieved all that we have.”
 
This is an article from August 2024
I'm glad I saved the article, as I wondered for a moment if I were going mad. It is from today (it is on the front page of Pulse, under "Latest"); the date has been changed from 2025 to 2024 for some reason. It references the DecodeME results and the delivery plan, so is not from 2024, and, a few hours ago when I saw this, the date was 2025, as you can see:

x.jpg
Very recent research from the ground-breaking Decode ME study confirmed these findings. It also showed marked genetic differences in those individuals who have ME/CFS concerning the immune system and neurological system.
Why am I writing about this? Well, the NHS recently announced that there will be ME/CFS clinics set up in neighbourhood heath centres as part of the 10-year plan. This is long overdue. The pathway for these conditions up until recently has either been non-existent or absolutely horrendous. Possible treatments are still sadly mostly ineffective or more likely not tested in good trials.
 
They responded. Here’s PG’s comment:

I don’t understand the criticism. The point is that now we know what the associations are, as opposed to not knowing before DecodeME.
I have no idea what the "nothing unique" criticism is supposed to be about. Nobody ever said that, and it doesn't even matter. This is about as close to just calling it poopyface as it gets while using fake language that may sound like legitimate criticism.
 
Today's Nature Briefing newsletter linked to Science's article about DecodeME, which has been previously posted in this thread.

"Genetic signs of chronic fatigue syndrome

A huge genomewide study has unveiled tentative “genetic signals” that might help understand the risk factors underlying myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) — a condition that affects millions of people, with symptoms such as debilitating exhaustion. In the genomes of more than 15,000 people with ME/CFS, researchers found eight genomic regions associated with the illness. The study provides “validation of ME/CFS as a biomedical condition and an important corrective to psychologizing ‘all in the mind’ perspectives on the disease”, says biopsychologist and epidemiologist Jos Bosch."
 

In ME/CFS patients, something in the body can now be identified that is linked to the disease​



First big Dutch newspaper I found reporting it. It's a tough thing to google for though.
Finally!
 
Article in the german Deutsches Ärzteblatt (paper for medical doctors, requires account):

Deepl translate:

ME/CFS: Evidence of genetic predisposition found – Deutsches Ärzteblatt
Deutscher Ärzteverlag GmbH, Editorial Office Deutsches Ärzteblatt

August 11, 2025

https://www.aerzteblatt.de/news/mecfs-hinweise-auf-genetische-pradisposition-gefunden
Edinburgh – A genome-wide association study (GWAS) has found genetic variants in eight genes that occur more frequently in patients with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) than in other people and offer explanations for an organic cause of the disease, which often occurs after infections and is thought to affect 67 million people worldwide.

Some patients recover slowly from viral infections. They often suffer from fatigue for weeks or months, which prevents them from participating in public life again. The best-known post-infectious fatigue is Long COVID following infection with SARS-CoV-2.

Even after the flu or Pfeiffer's glandular fever, which is caused by infection with the Epstein-Barr virus, a prolonged phase of fatigue can occur. An extreme variant is myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), which also often follows an infection (usually without specific evidence of a pathogen).

The main symptom is post-exertional malaise. Even minor physical or mental activities trigger a significant deterioration in health. Other symptoms include cognitive impairment (“brain fog”), myalgia, and sleep disorders. Due to the unclear symptoms and lack of laboratory markers, patients quickly gain a reputation for letting themselves go or merely feigning the illness. Others receive a psychiatric diagnosis such as depression.

One goal of the DecodeME study was therefore to prove the biological basis of the disease, which most sufferers and their interest groups are convinced of, by identifying genetic markers.

Through social and traditional media and with the help of self-help organizations, 21,620 sufferers were found, most of whom sent a saliva sample to the study center at the University of Edinburgh. There, 15,579 samples have been analyzed so far and compared with 259,909 participants in the UK Biobank for genetic variants (single nucleotide polymorphisms, SNPs).

The team led by Chris Ponting from the University of Edinburgh found significant associations at eight gene loci. Four of these were located in or near genes involved in the immune defense against infections: BTN2A2 inhibits T-cell activation. A genetic defect could lead to an excessive immune response. OLFM4 encodes the protein olfactomedin-4, which has an inhibitory effect on neutrophil granulocytes. Here, too, a defect could strengthen the immune response.

This could also be the case with genetic defects in RABGAP1L, which is also involved in the defense against bacteria and viruses. ZNFX1 is a virus sensor that regulates the interferon response. Another SNP is located in the CA10 gene, which is thought to be involved in pain processing in the brain. In the GWAS, the variant was associated with chronic pain. According to Ponting, the symptoms of ME/CFS can easily be misinterpreted as depression.

One argument in favor of separating the two diseases is that the eight significant associations of ME/CFS did not overlap with the SNPs found in other GWAS in patients with depression. However, there were associations that remained below the significance level. It is important for the evidence presented in a GWAS that the results are confirmed in further cohorts. This was only partially successful.

However, four signals, including OLFM4 and CA10, were also found in ME/CFS patients in the British Biobank and in a Dutch cohort. The British DecodeME team is calling on scientists in other countries to look for the associations in their patients. The clinical benefit of the study, which has not yet undergone the peer review process, is likely to be limited for the time being.

According to Ponting, a genetic test or specific therapy recommendations are not currently expected. Other experts have only just begun to delve into the results. Jackie Cliff of Brunel University of London, for example, is fascinated by the connection with the FBXL4 gene, which is involved in mitochondrial function.

Defects in this gene could plausibly explain the main symptom of post-exertional malaise. Alena Pance from the University of Hertfordshire in Hatfield finds no explanation for the unequal gender distribution. Two-thirds of ME/CFS sufferers are women. However, the researchers did not include sex chromosomes in their analysis.


Links

Zum Preprint
https://www.pure.ed.ac.uk/ws/portalfiles/portal/533352490/Preprint.pdf
Pressemitteilung der Universität Edinburgh

Expertenmeinung im Science Media Center
Homepage vom DecodeME
Translated with DeepL.com (free version)


About the journal -- from Wikipedia:

Deutsches Ärzteblatt is published by the Deutscher Ärzte Verlag, which is co-owned by the German Medical Association (Bundesärztekammer) and the National Association of Statutory Health Insurance Physicians (Kassenärztliche Bundesvereinigung). It is the official journal of these two bodies, distributed to all physicians in Germany.
 
Last edited:
Austrian newspaper Der Standard: https://www.derstandard.at/story/30...netischer-hintergrund-von-mecfs-identifiziert
AI translation of the article:


CHRONIC FATIGUE​

Possible Genetic Background of ME/CFS Identified

DNA analyses of more than 15,500 affected individuals have identified eight preliminary genetic signals. This provides increasingly clear evidence that the disease does not have a psychological origin.

By Pia Kruckenhauser
August 12, 2025, 09:00

People with ME/CFS have severely impaired capacity. About a quarter of them cannot even leave their homes. Many others are unable to hold a full-time job. Extended computer work or driving causes their concentration to completely vanish.

It is a disease that affects around 80,000 people in Austria—with a potentially higher number of unreported cases—but cannot be clearly diagnosed in practice. ME/CFS, Myalgic Encephalomyelitis / Chronic Fatigue Syndrome, is currently diagnosed only by exclusion, since there are no definitive biomarkers that can be clinically tested. Since the Covid-19 pandemic, the number of affected individuals has reportedly doubled or even tripled—it is considered a form of Long Covid. This has contributed to research on the condition being ramped up in many countries.

Recently, possible indications in the gut microbiome were found; now, another study has been published showing genetic anomalies that may be responsible for ME/CFS. The publication is a preprint and has not yet been peer-reviewed.

This is the largest DNA study in the world regarding this disease, which presents with, at times, quite unspecific symptoms. Typical are neurocognitive and immunological symptoms like rapid heartbeat, dizziness, lightheadedness, fluctuating blood pressure, headaches, muscle and joint pain, gastrointestinal problems, issues with concentration, memory, and word-finding (a kind of “brain fog”), sleep disturbances, and hypersensitivity to sensory stimuli. Symptoms vary among individuals, complicating diagnosis.

The most typical symptom experienced by nearly all patients is post-exertional malaise (PEM): a pronounced and persistent intensification of all symptoms after minor physical or mental effort. This leads to severe weakness, muscle pain, flu-like symptoms, and an overall deterioration in condition. PEM can be triggered even by minor exertion—small activities such as brushing teeth, showering, cooking, or taking a few steps can become an ordeal, and a trip to the supermarket can mean days of bed rest afterward.

Triggered by Viral Infection​

To uncover possible genetic traits, researchers analyzed the DNA of over 15,000 affected individuals, identifying eight genome regions associated with ME/CFS. Some overlap with genes related to the immune response to infections, or are located nearby. This is notable since the disease is practically always triggered by (severe) viral infection. In principle, any virus could trigger ME/CFS, such as influenza, but it is particularly common after Epstein-Barr or Covid infection—hence the considerable increase during the pandemic.

“The study confirms ME/CFS as a biomedical disease. It is also an important correction to the psychological view of the disease, which often assesses the symptoms as psychological problems,” says Jos Bosch, biopsychologist and epidemiologist at the University of Amsterdam, who advised the project but did not participate in the research. Although this type of genetic study cannot definitively determine the causes, the identified areas of the genome merit further investigation, he adds.

For a long time, people with ME/CFS had to fight against the assumption that their illness was psychological rather than physical, writes the journal Science in an analysis of the study. Previous attempts to determine genetic causes or risk factors for ME/CFS were hindered by small participant numbers and broad or inconsistent diagnostic criteria. The goal of the current project, funded with £3.2 million by the UK government in 2022, was to overcome these hurdles with the largest genome-wide association study (GWAS) to date. The so-called DecodeME analysis was carried out with the participation of patients, caregivers, and charities.

Questionnaire and Saliva Sample​

Through online marketing, social media, and other recruitment efforts, the team engaged more than 26,000 people to complete a questionnaire about disease symptoms and other information. Some 21,000 reported having received a clinical diagnosis of ME/CFS from a doctor, experienced discomfort after physical activity, and had other symptoms matching standard diagnostic criteria for the disease. Around 18,000 also submitted a saliva sample for DNA testing.

For their analysis, researchers examined the samples of 15,579 participants of European descent, comparing their genomes to healthy participants from the UK Biobank study. In particular, the team looked for single-nucleotide polymorphisms (SNPs)—differences in individual DNA bases—that could distinguish the two groups.

By combining multiple analyses, the researchers ultimately identified eight DNA regions that differed significantly between the groups. These included regions containing genes or near genes involved in neurological and immunological processes. One such gene, OLFM4, codes for a protein called olfactomedin-4, which is involved in the body’s antimicrobial responses. Another, ZNFX1, is linked to responses to RNA viruses. A third highlighted gene, CA10, is associated with chronic pain.

The team also searched other national biobanks with ME/CFS patients for the same genetic associations. Many results could not be reproduced, though there was some correlation with fatigue after exertion for four genes—including OLFM4 and CA10—among British Biobank and a Dutch cohort. These discrepancies might be due to different criteria defining the disease, says study co-author Chris Ponting, a human geneticist in Edinburgh.

Abandoned by the Medical Establishment​

Doug Speed, a statistical geneticist at Aarhus University who was not involved in the work, rates the team’s approach positively but emphasizes that the genetic associations explain only a small part of an individual’s ME/CFS risk. Most variation remains unexplained. “That’s largely to be expected,” he told Science. For many human diseases, “the risk is influenced by many thousands of genetic variants, each of which has a minuscule effect on its own.”

More than 85% of participants consented to sharing their data with other approved researchers, reports the DecodeME team. Sonya Chowdhury, CEO of the British charity Action for ME and co-author of the preprint, adds: “Our findings give the experiences of people with ME/CFS credibility and validity. Still, there is much to be done to develop treatments.”

This study represents an important step for the community. Many feel abandoned by the medical establishment, emphasizes Andy Devereux-Cooke, himself affected by ME/CFS and involved in patient and public outreach for the DecodeME study: “Even though the research does not provide all the answers or practical help, it is nevertheless a welcome drop in the ocean to help turn the tide.”

The project is part of a remarkable increase in ME/CFS research in recent years. This is due to increasingly active patient advocacy, the waning of psychological and behavioral explanations for the disease, and the emergence of new awareness due to its similarity with Long Covid, says biopsychologist Bosch. He and his team, together with patient organizations in the Netherlands, are conducting a large-scale study on ME/CFS, Long Covid, and other post-viral conditions. The project, with several hundred participants so far, will analyze muscle and post-mortem brain tissue as well as brain images from patients. (Pia Kruckenhauser, 12.8.2025)


  1. https://de.wikipedia.org/wiki/Myalgische_Enzephalomyelitis/Chronisches_Fatigue-Syndrom
  2. https://pmc.ncbi.nlm.nih.gov/articles/PMC9281337/
  3. https://pmc.ncbi.nlm.nih.gov/articles/PMC11093804/
  4. https://www.usz.ch/krankheit/chronische-muedigkeit/
  5. https://www.mecfs.de/was-ist-me-cfs/pacing/
  6. https://www.iqwig.de/download/n21-01_me-cfs-aktueller-kenntnisstand_abschlussbericht_v1-0.pdf
  7. https://www.mecfs.de/was-ist-me-cfs/
  8. https://mecfs-research.org/was-ist-me-cfs/
  9. https://www.gesundheitsinformation....halomyelitis-chronisches-fatigue-syndrom.html
  10. https://immunologie.charite.de/fileadmin/user_upload/microsites/m_cc12/immunologie/Immundefekt-Ambulanz/CFS_eine_unterschätzte_Erkrankung.pdf
 
I'm glad I saved the article, as I wondered for a moment if I were going mad. It is from today (it is on the front page of Pulse, under "Latest"); the date has been changed from 2025 to 2024 for some reason. It references the DecodeME results and the delivery plan, so is not from 2024, and, a few hours ago when I saw this, the date was 2025, as you can see:

View attachment 27737
does it say who it is written by?
 
Deepl translate:




About the journal -- from Wikipedia:

Deutsches Ärzteblatt is published by the Deutscher Ärzte Verlag, which is co-owned by the German Medical Association (Bundesärztekammer) and the National Association of Statutory Health Insurance Physicians (Kassenärztliche Bundesvereinigung). It is the official journal of these two bodies, distributed to all physicians in Germany.

I thought this bit was intersting:

One argument in favor of separating the two diseases is that the eight significant associations of ME/CFS did not overlap with the SNPs found in other GWAS in patients with depression. However, there were associations that remained below the significance level. It is important for the evidence presented in a GWAS that the results are confirmed in further cohorts. This was only partially successful.

However, four signals, including OLFM4 and CA10, were also found in ME/CFS patients in the British Biobank and in a Dutch cohort.
 
GPs owe ME/CFS patients an apology (PulseToday, 11 August 2025)

The mechanistic stuff is wrong but the attitude is quite a refreshing change.


Thanks to Shnickelfritz on twitter/X for screenshots of the Pulse article.

This section of the Pulse article appears to announce that the DecodeME results confirms the 'Central sensitization' ideology, and then tags on 'patients with a history of trauma, abuse or adverse childhood events [ACEs] are more likely to have these conditions', ie ME/CFS, Fibromyalgia and/or PTSD.

Does the DecodeME study actually confirm 'Central sensitization' in ME?
Or does the Pulse article wildly extrapolate?


Pulse - '… It appears that underlying ME/CFS and fibromyalgia (and also likelyPTSD) is a dysregulated and excessive immune response to either infection or acute stress. This releases (scientifically and experimentally proven) very high levels of inflammatory cytokines andIl-6 which then affects the brain, central nervous system and also the hypothalamic-pituitary axis.

The nervous systems remains in a neuro-inflammatory state with the imprint of this hyper-immune inflammatory response forever imprinted on it.
'Central sensitization' is a term that is often used.

Very recent research from the groundbreaking DecodeME study confirmed these findings.
It also showed marked genetic differences in those individuals who have ME/CFS concerning the immune system and neurological system.

Acute infections and acute stress and trauma can both do this, like a severe 'fight or flight' response. This is why patients and individuals with a history of trauma, abuse or adverse childhood events [ACEs] are more likely to have these conditions.'

End of Pulse quote.



 
Last edited:
Back
Top Bottom